OBI-3424

OBI-3424 Uses, Dosage, Side Effects, Food Interaction and all others data.

OBI-3424 is under investigation in clinical trial NCT04315324 (Study to Test Akr1c3-activated Prodrug OBI-3424 (OBI-3424) in Patients With Relapsed/refractory T-cell Acute Lymphoblastic Leukemia (T-ALL)).

Trade Name OBI-3424
Generic OBI-3424
Type
Formula C21H25N4O6P
Weight Average: 460.427
Monoisotopic: 460.151171539
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
OBI-3424
OBI-3424

Innovators Monograph

You find simplified version here OBI-3424

*** Taking medicines without doctor's advice can cause long-term problems.
Share